Document Detail


Maximal conservative therapy of calcific uremic ateriolopathy.
MedLine Citation:
PMID:  22732339     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
We present the case of a 61-year- old female patient in long-term hemodialysis who developed calcific uremic arteriolopathy (CUA) upon administration of the oral calcimimetic agent cinacalcet for treatment of secondary hyperparathyroidism. In May 2009, the baseline serum values were parathormone (PTH) 310 pg/ml, calcium 9.1 mg/dl and phosphorous 6.9 mg/dl. Necrotic wounds in the suprapubic fat tissue were successfully treated first, by correcting the calcium phosphorous product; second, through treatment with sodium thiosulfate and third, through intensive wound care with hyperbaric oxygen therapy and vacuum-assisted closure therapy, with no need for parathyroidectomy. Multiple factors have been described to play a role in the development of CUA. Based on the findings of this case, the treatment of CUA should be aimed at correcting different causes simultaneously.
Authors:
Charlotte Van Noten; Karin Janssen van Doorn; Evert Vermander; Sonja Vlayen; Gert A Verpooten; Marie-Madeleine Couttenye
Related Documents :
6337529 - The success rate of fibrinolytic therapy in fresh and old thrombosis of the iliac and f...
17635709 - Is it worth diagnosing and treating distal deep vein thrombosis? no.
22395509 - Healing process and laser therapy in the superficial periodontium: a histological study.
6344819 - A randomized study of beef lung and pork mucosal heparin in cardiac surgery.
9070519 - Prevention of thromboembolism with use of recombinant hirudin. results of a double-blin...
15227689 - Randomized clinical trial of low molecular weight heparin with thigh-length or knee-len...
18299499 - Patient outcomes after deep vein thrombosis and pulmonary embolism: the worcester venou...
11180899 - Revision of failed metal-backed patellar component of miller/galante-i total knee prost...
7859799 - Safety and efficacy of lifibrol upon four-week administration to patients with primary ...
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  Clinical nephrology     Volume:  78     ISSN:  0301-0430     ISO Abbreviation:  Clin. Nephrol.     Publication Date:  2012 Jul 
Date Detail:
Created Date:  2012-06-26     Completed Date:  2012-08-07     Revised Date:  2013-05-30    
Medline Journal Info:
Nlm Unique ID:  0364441     Medline TA:  Clin Nephrol     Country:  Germany    
Other Details:
Languages:  eng     Pagination:  61-3     Citation Subset:  IM    
Affiliation:
Department of Nephrology-Hypertension, Antwerp University Hospital, Belgium.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Arterioles / drug effects,  pathology
Calcimimetic Agents / adverse effects*
Chelating Agents / therapeutic use*
Combined Modality Therapy
Diabetes Mellitus, Type 2 / complications
Diabetic Nephropathies / etiology,  therapy*
Female
Humans
Hyperbaric Oxygenation*
Kidney Failure, Chronic / etiology,  therapy*
Middle Aged
Naphthalenes / adverse effects*
Negative-Pressure Wound Therapy*
Renal Dialysis
Thiosulfates / therapeutic use*
Treatment Outcome
Uremia / complications*,  etiology,  therapy*
Vascular Calcification / chemically induced,  pathology,  therapy*
Chemical
Reg. No./Substance:
0/Calcimimetic Agents; 0/Chelating Agents; 0/Naphthalenes; 0/Thiosulfates; 7772-98-7/sodium thiosulfate; UAZ6V7728S/cinacalcet

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Clinical and pathological spectrums of aristolochic acid nephropathy.
Next Document:  Cystatin C and acute changes in glomerular filtration rate.